Latest News of NUVL
Nuvalent, Inc. (NUVL) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
2 months ago
Nuvalent, a biopharmaceutical company, has initiated a public offering of $350 million of its Class A common stock to support its cancer-focused kinase therapies. The completion of the offering is sub...
Nuvalent, Inc. (NUVL): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance |
2 months ago
The article discusses the risks and potential rewards of investing in biotechnology stocks, focusing on Nuvalent, Inc. (NASDAQ:NUVL). It highlights the importance of deep analysis, diversification, an...
Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock
By Yahoo! Finance |
2 months ago
Nuvalent, Inc. is a biopharmaceutical company focusing on developing targeted cancer therapies. Despite being ranked 4th on the list of worst cancer stocks by short sellers, Nuvalent has strong market...